The Effect of Xolair (Omalizumab) on Allergy Blood Cells
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
We are studying Xolair (omalizumab) to see it's effect on allergic blood cells. The blood
tests will be done in a test tube to see if they react differently before and after
treatment. The blood cells will be mixed with to whatever the person is allergic.